These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27030211)

  • 21. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.
    Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L
    J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LATS2 condensates organize signalosomes for Hippo pathway signal transduction.
    Qin M; Geng E; Wang J; Yu M; Dong T; Li S; Zhang X; Lin J; Shi M; Li J; Zhang H; Chen L; Cao X; Huang L; Wang M; Li Y; Yang XP; Zhao B; Sun S
    Nat Chem Biol; 2024 Jun; 20(6):710-720. PubMed ID: 38200110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
    Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl.
    Reuven N; Adler J; Meltser V; Shaul Y
    Cell Death Differ; 2013 Oct; 20(10):1330-40. PubMed ID: 23852372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
    Salah Z; Itzhaki E; Aqeilan RI
    Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
    Song L; Huang Y; Zhang X; Han S; Hou M; Li H
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer.
    Kim Y; Jho EH
    BMB Rep; 2017 Jun; 50(6):281-282. PubMed ID: 28502290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma.
    Guo C; Liang C; Yang J; Hu H; Fan B; Liu X
    Oncol Rep; 2019 May; 41(5):2753-2761. PubMed ID: 30896861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.
    He C; Lv X; Huang C; Hua G; Ma B; Chen X; Angeletti PC; Dong J; Zhou J; Wang Z; Rueda BR; Davis JS; Wang C
    EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30755404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.
    Lee DH; Park JO; Kim TS; Kim SK; Kim TH; Kim MC; Park GS; Kim JH; Kuninaka S; Olson EN; Saya H; Kim SY; Lee H; Lim DS
    Nat Commun; 2016 Jun; 7():11961. PubMed ID: 27358050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation.
    Zhou J; Zeng Y; Cui L; Chen X; Stauffer S; Wang Z; Yu F; Lele SM; Talmon GA; Black AR; Chen Y; Dong J
    Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6760-E6769. PubMed ID: 29967145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
    Mohad V; Lungova V; Verheyden J; Thibeault SL
    Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
    Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
    J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.
    Qin H; Blaschke K; Wei G; Ohi Y; Blouin L; Qi Z; Yu J; Yeh RF; Hebrok M; Ramalho-Santos M
    Hum Mol Genet; 2012 May; 21(9):2054-67. PubMed ID: 22286172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.